Latest filing published 26 Aug 2024 for Agile Therapeutics INC, €14k.
Insider track record
Geoffrey Gilmore: trading record in brief
This profile gathers the share dealings of Geoffrey Gilmore in Agile Therapeutics Inc. Over a trading history stretching from 25 January 2018 to 26 August 2024, the count stands at 10 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 26 August 2024, reports a transaction of €14k in Agile Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Geoffrey Gilmore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,131 shares@ US$1.5217.5% of flowCommon StockSEC:0001104659-24-092947:1
- 10,125 shares@ US$1.52100.0% of flowCommon StockSEC:0001104659-24-092947:0
- 6,716 shares0Common StockSEC:0001104659-23-077174:1
- 13,500 shares0Common StockSEC:0001104659-23-077174:0
- 25,500 shares@ US$1.5672.1% of flowCommon StockSEC:0001104659-20-034104:0
- 10,071 shares0Common StockSEC:0001104659-20-006860:0
- 16,480 sharesCommon StockSEC:0001104659-19-003714:0
- 17,500 sharesCommon StockSEC:0001104659-19-003714:1
- 17,500 sharesCommon StockSEC:0001104659-18-004317:0
- 5,768 shares@ US$3.3223.8% of flowCommon StockSEC:0001104659-18-004317:1
10 of 10 declarations